Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States

Author:

Thompson Ryan R1,Kong Christina L1,Porco Travis C123,Kim Eric1,Ebert Caleb D1,Acharya Nisha R1234

Affiliation:

1. Francis I. Proctor Foundation, University of California, San Francisco, California, USA

2. Department of Ophthalmology, University of California, San Francisco, California, USA

3. Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA

4. OptumLabs Visiting Fellow, Cambridge, Massachusetts, USA

Abstract

Abstract Background The incidence of herpes zoster (HZ) has been increasing in recent decades. Although 2 vaccines for HZ are available, there have been few studies on the incidence rates of HZ and postherpetic neuralgia (PHN) since their introduction. This study examined the incidence rates of HZ and PHN from 1994 to 2018 in the United States to determine if they have continued to increase since introduction of the HZ vaccines. Methods A de-identified longitudinal administrative claims database, the OptumLabs Data Warehouse, was used to assess incidence rates among individuals continuously enrolled in the database for ≥365 days with no prior history of HZ or PHN. Unstandardized and standardized incidence rates were calculated by year, 10-year age groups, sex, and race/ethnicity. Results There were 610 766 individuals with HZ (median age, 56.3; interquartile range, 43.0–68.7 years; 59.8% women; 70.6% white). From 1994 to 2018, the incidence of HZ increased from 286.0 (95% confidence interval [CI], 259.1–312.8) to 579.6 (95% CI, 554.2–605.0) cases per 100 000 person-years, an annual increase of 3.1% (95% CI, 2.5–3.6%). Since 2007, annual HZ incidence rates have decreased in individuals ≤20 and >60 years old. The overall incidence rate of PHN was 57.5 (95% CI, 56.0–59.0) cases per 100 000 person-years. The proportion of individuals with HZ who developed PHN was higher from 2007 to 2018 than from 1994 to 2006. Conclusions HZ incidence rates have continued to increase in age groups for which HZ vaccines are not currently recommended, warranting a review of current vaccine recommendations.

Funder

National Eye Institute

Office of Research on Women’s Health

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference38 articles.

1. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults;Lal;N Engl J Med,2015

2. Herpes zoster incidence among insured persons in the united states, 1993–2006: evaluation of impact of varicella vaccination;Leung;Clin Infect Dis,2011

3. The incidence of herpes zoster in a United States administrative database;Insinga;J Gen Intern Med,2005

4. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP);Harpaz;MMWR Recomm Rep,2008

5. Post-herpetic neuralgia—a review of current management and future directions;Schutzer-Weissmann;Expert Opin Pharmacother,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3